(IBTG) iShares iBonds Dec 2026 - Ratings and Ratios
Treasury Bonds, 2026 Maturity, Government Debt
Dividends
| Dividend Yield | 4.03% |
| Yield on Cost 5y | 4.08% |
| Yield CAGR 5y | 53.48% |
| Payout Consistency | 99.2% |
| Payout Ratio | - |
| Risk via 5d forecast | |
|---|---|
| Volatility | 0.78% |
| Value at Risk 5%th | 1.17% |
| Relative Tail Risk | -8.39% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.44 |
| Alpha | 0.64 |
| CAGR/Max DD | 1.35 |
| Character TTM | |
|---|---|
| Hurst Exponent | |
| Beta | -0.014 |
| Beta Downside | -0.021 |
| Drawdowns 3y | |
|---|---|
| Max DD | 2.85% |
| Mean DD | 0.58% |
| Median DD | 0.18% |
Description: IBTG iShares iBonds Dec 2026 January 14, 2026
The iShares iBonds Dec 2026 Term Treasury ETF (NASDAQ: IBTG) is a U.S.-based target-maturity ETF that seeks to track an index of publicly-issued Treasury securities maturing between 1 Jan 2026 and 15 Dec 2026. The fund commits at least 80 % of its assets to the index’s component securities and at least 90 % to U.S. Treasuries that BlackRock believes will keep tracking error low. Because it is classified as “non-diversified,” a large share of the portfolio is concentrated in a single maturity bucket.
Key quantitative drivers (as of early 2024) include an expense ratio of roughly 0.20 %, a weighted-average yield near 4.5 % and an effective duration of about 2.0 years, making the ETF highly sensitive to movements in the 2-year Treasury curve. The fund’s performance is therefore closely tied to Federal Reserve policy, inflation expectations, and the shape of the short-end yield curve-particularly any shifts in the Fed’s rate-cut outlook.
If you want to dig deeper into IBTG’s risk-adjusted return metrics and how it fits within a broader fixed-income strategy, a quick look at ValueRay’s analytical tools can provide useful context.
What is the price of IBTG shares?
Over the past week, the price has changed by +0.09%, over one month by +0.31%, over three months by +0.89% and over the past year by +4.49%.
Is IBTG a buy, sell or hold?
What are the forecasts/targets for the IBTG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 24.7 | 7.7% |
IBTG Fundamental Data Overview January 14, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 2.37b USD (2.37b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 2.37b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 2.37b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 5.86% (E(2.37b)/V(2.37b) * Re(5.86%) + (debt-free company))
Discount Rate = 5.86% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for IBTG ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle